Contact

All Stories

  1. Gout – from history to the present

    Article • Reports of Vinnytsia National Medical University, December 2024, Vinnytsia National Pyrogov Memorial Medical University

    Nataliia Slepchenko

  2. Application of ChatGPT for clinical decision-making in patients with community-acquired pneumonia.

    Article • September 2024, European Respiratory Society (ERS)

    Nataliia Slepchenko

  3. Assessing the potential of using ChatGPT by patients with asthma

    Article • September 2024, European Respiratory Society (ERS)

    Nataliia Slepchenko

  4. How medical students use ChatGPT?

    Article • September 2024, European Respiratory Society (ERS)

    Nataliia Slepchenko

  5. Opportunities of using ChatGPT for smoking cessation

    Article • September 2024, European Respiratory Society (ERS)

    Nataliia Slepchenko

  6. POSSIBILITY OF USING ARTIFICIAL INTELLIGENCE CHATGPT (GENERATIVE PRE-TRAINING TRANSFORMER) IN RESOLVING CLINICAL CASES OF PATIENTS WITH COMMUNITY-ACQUIRED PNEUMONIA (GENERATIVE PRE-TRAINING TRANSFORMER) IN RESOLVING CLINICAL CASES OF PATIENTS WITH COMM...

    Article • Ukrainian Pulmonology Journal, January 2024, Ukrainian Pulmonary Journal

    Nataliia Slepchenko

  7. POSSIBILITIES OF USING CHATBOTS WITH ARTIFICIAL INTELLIGENCE FOR TOBACCO CONTROL

    Article • Ukrainian Pulmonology Journal, January 2024, Ukrainian Pulmonary Journal

    Nataliia Slepchenko

  8. Adherence to COPD treatment and concomitant diseases: is there influence ?

    Article • September 2023, European Respiratory Society (ERS)

    Nataliia Slepchenko

  9. Adherence to COPD treatment during the war: can we maintain the previously achieved results ?

    Article • September 2023, European Respiratory Society (ERS)

    Nataliia Slepchenko

  10. Impact of pharmacotherapy with tiotropium/olodaterol on the pulmonary function in COPD patients depending on the Arg16Gly polymorphism of ADRB2 gene

    Article • Reports of Vinnytsia National Medical University, September 2022, Vinnytsia National Pyrogov Memorial Medical University

    Nataliia Slepchenko

  11. Clinical course of COPD in patients with Arg16Gly (rs1042713) polymorphism of <em>ADRB2</em> gene

    Article • Monaldi Archives for Chest Disease, September 2022, PAGEPress Publications

    Nataliia Slepchenko

  12. COPD clinical course in patient with Gln27Glu polymorphism of ADRB2 gene

    Article • September 2022, European Respiratory Society (ERS)

    Nataliia Slepchenko

  13. How COPD patients with Gln27Glu polymorphism utilize exacerbation-related drugs?

    Article • September 2022, European Respiratory Society (ERS)

    Nataliia Slepchenko

  14. How does Arg16Gly polymorphism affect pulmonary function and treatment response in COPD patients?

    Article • September 2022, European Respiratory Society (ERS)

    Nataliia Slepchenko

  15. Role of ADRB2 gene haplotypes in the clinical course of COPD

    Article • September 2022, European Respiratory Society (ERS)

    Nataliia Slepchenko

  16. Utilization of exacerbation-related drugs by COPD patients with Arg16Gly polymorphism of ADRB2 gene

    Article • September 2022, European Respiratory Society (ERS)

    Nataliia Slepchenko

  17. Co-morbidities in COPD patients with Arg16Gly polymorphism of ADRB2 gene

    Article • September 2022, European Respiratory Society (ERS)

    Nataliia Slepchenko

  18. Impact of pharmacotherapy with tiotropium/olodaterol on the pulmonary function in COPD patients depending on the Arg16Gly polymorphism of ADRB2 gene

    Article • Infusion & Chemotherapy, July 2022, Communicable Diseases Intensive Care Association

    Nataliia Slepchenko

  19. Does the Gln27Gln polymorphism of the adrenoreceptor beta 2 gene affect the clinical course of chronic obstructive pulmonary disease?

    Article • Biomedical Research and Therapy, May 2022, Biomedical Research and Therapy

    Nataliia Slepchenko

  20. EFFICACY OF COMBINATION OF TIOTROPIUM/OLODATEROL IN PATIENTS WITH COPD IN REAL CLINICAL PRACTICE

    Article • Wiadomości Lekarskie, January 2022, ALUNA

    Nataliia Slepchenko

  21. CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND CARDIOVASCULAR PATHOLOGY WITH FOCUS ON ARRHYTHMIAS

    Article • Ukrainian Pulmonology Journal, January 2022, Ukrainian Pulmonary Journal

    Nataliia Slepchenko

  22. Admission due to heart failure and pulmonary function testing: is there a COPD?

    Article • September 2021, European Respiratory Society (ERS)

    Nataliia Slepchenko

  23. Is there a role of Heart Failure in pulmonary function testing?

    Article • September 2021, European Respiratory Society (ERS)

    Nataliia Slepchenko

  24. Efficacy of instant messages applications in smoking cessation in patients with COPD

    Article • September 2021, European Respiratory Society (ERS)

    Nataliia Slepchenko

  25. Reversibility at pulmonary function tests: can it have implications in patients with COPD?

    Article • September 2021, European Respiratory Society (ERS)

    Dr Kostiantyn Dmytriiev, Nataliia Slepchenko

  26. Features of the COPD course in patients with different alleles of C79G (rs1072714) of ADRB2 gene

    Article • Biomedical and Biosocial Anthropology, March 2021, Vinnytsia National Pyrogov Memorial Medical University

    Nataliia Slepchenko

  27. EFFECT OF COMBINATION OF TIOTROPIUM/ OLODATEROL ON PULMONARY FUNCTION IN PATIENTS WITH COPD IN THE REAL CLINICAL PRACTICE

    Article • Ukrainian Pulmonology Journal, January 2021, Ukrainian Pulmonary Journal

    Nataliia Slepchenko

  28. PECULIARITIES OF THE COURSE OF COPD IN PATIENTS WITH DIFFERENT A46G (RS1042713) ALLELES OF ADRB2 GENE

    Article • Ukrainian Pulmonology Journal, January 2021, Ukrainian Pulmonary Journal

    Nataliia Slepchenko

  29. ASTHMA AND SMOKING

    Article • Ukrainian Pulmonology Journal, January 2021, Ukrainian Pulmonary Journal

    Nataliia Slepchenko

  30. Can reversibility determine clinical course in patients with COPD?

    Article • September 2020, European Respiratory Society (ERS)

    Dr Kostiantyn Dmytriiev, Nataliia Slepchenko

  31. “Smoking” vs “non-smoking” COPD: how dramatic is the difference?

    Article • September 2020, European Respiratory Society (ERS)

    Dr Kostiantyn Dmytriiev, Nataliia Slepchenko

  32. Do technologies make a difference in adherence to treatment: instant messaging application use?

    Article • September 2020, European Respiratory Society (ERS)

    Nataliia Slepchenko

  33. Budesonide/formoterol efficacy in “obese” asthma

    Article • September 2020, European Respiratory Society (ERS)

    Nataliia Slepchenko

  34. Does heart failure make a difference in pulmonary function testing?

    Article • September 2020, European Respiratory Society (ERS)

    Nataliia Slepchenko

  35. COPD exacerbations and adherence to treatment improvement:what goal can be achieved?

    Article • September 2020, European Respiratory Society (ERS)

    Nataliia Slepchenko

  36. Spirometry parameters and adherence to COPD treatment: is there association?

    Article • September 2020, European Respiratory Society (ERS)

    Nataliia Slepchenko

  37. INFLUENCE OF BASIC COMBINED BRONCHOLYTIC THERAPY ON THE COURSE OF COPD: RESULTS OF INTERNATIONAL RESEARCH AND REGIONAL SUBANALYSIS

    Article • Ukrainian Pulmonology Journal, January 2020, Ukrainian Pulmonary Journal

    Nataliia Slepchenko

  38. CLINICO-FUNCTIONAL ASSESSMENT OF COPD COURSE IN PATIENT WITH DIFFERENT REVERSIBILITY OF BRONCHIAL OBSTRUCTION

    Article • Asthma and allergy, January 2020, Asthma and Allergy

    Nataliia Slepchenko

  39. PULMONARY EMBOLISM AND PULMONARY DISEASES. KEY STATEMENTS OF 2019 ERS/ESC GUIDELINES FOR THE DIAGNOSIS AND MANAGEMENT OF ACUTE PULMONARY EMBOLISM

    Article • Ukrainian Pulmonology Journal, January 2020, Ukrainian Pulmonary Journal

    Nataliia Slepchenko

  40. Immediate effects of smoking: does tobacco and electronic cigarettes differ?

    Article • September 2019, European Respiratory Society (ERS)

    Nataliia Slepchenko, Dr Kostiantyn Dmytriiev

  41. Budesoinde/formoterol: does eosinophil count cause different outcomes?

    Article • September 2019, European Respiratory Society (ERS)

    Dr Kostiantyn Dmytriiev, Nataliia Slepchenko

  42. ADHERENCE TO COPD TREATMENT: IS IT REALLY OF CRUCIAL IMPORTANCE?

    Article • Asthma and allergy, January 2019, Asthma and Allergy

    Dr Kostiantyn Dmytriiev, Nataliia Slepchenko

  43. ASTHMA AND THE HEART

    Article • Ukrainian Pulmonology Journal, January 2019, Ukrainian Pulmonary Journal

    Dr Kostiantyn Dmytriiev, Nataliia Slepchenko

  44. MODERN APPROACHES TO THE INHALATION THERAPY IN PULMONARY BRONCHOOBSTRUCTIVE PATHOLOGY

    Article • Asthma and allergy, January 2019, Asthma and Allergy

    Dr Kostiantyn Dmytriiev, Nataliia Slepchenko

  45. INSUFFICIENT ADHERENCE TO COPD BASIS THERAPY: WHAT FACTORS ARE DETERMINING?

    Article • Asthma and allergy, January 2019, Asthma and Allergy

    Nataliia Slepchenko

  46. ROLE OF E-CIGARETTES IN THE SMOKING CESSATION

    Article • September 2018, European Respiratory Society (ERS)

    Dr Kostiantyn Dmytriiev, Nataliia Slepchenko

  47. ADHERENCE TO TREATMENT: METHODS OF ITS IMPROVEMENT IN THE INHALATION THERAPY OF BRONCHIAL ASTHMA

    Article • Ukrainian Pulmonology Journal, January 2018, Ukrainian Pulmonary Journal

    Dr Kostiantyn Dmytriiev, Nataliia Slepchenko

  48. CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND THE HEART: ACHIEVMENTS AND CURRENT QUESTIONS

    Article • Ukrainian Pulmonology Journal, January 2018, Ukrainian Pulmonary Journal

    Dr Kostiantyn Dmytriiev, Nataliia Slepchenko

  49. INFLUENCE OF GENETIC FACTORS ON THE DEVELOPMENT AND COURSE OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE

    Article • Ukrainian Pulmonology Journal, January 2018, Ukrainian Pulmonary Journal

    Dr Kostiantyn Dmytriiev, Nataliia Slepchenko

  50. Budesonid/formoterol easyhaler: clinical efficiency and adherence to treatment in patients with partly controlled bronchial asthma (BA)

    Article • September 2017, European Respiratory Society (ERS)

    Dr Kostiantyn Dmytriiev, Nataliia Slepchenko

  51. Decline in health status in alpha1 antitrypsin deficiency

    Article • September 2017, European Respiratory Society (ERS)

    Nataliia Slepchenko

  52. Author Index

    Article • European Heart Journal, September 2014, European Society of Cardiology

    Nataliia Slepchenko